Article
Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.
PloS one - 1 Jan 2012
Caugant Dominique A, Kristiansen Paul A, Wang Xin, Mayer Leonard W, Taha Muhamed-Kheir, Ouédraogo Rasmata, Kandolo Denis, Bougoudogo Flabou, Sow Samba, Bonte Laurence
Abstract excerpt
BACKGROUND: The serogroup A conjugate meningococcal vaccine, MenAfriVac, was introduced in mass vaccination campaigns in December 2010 in Burkina Faso, Mali and Niger. In the coming years, vaccination will be extended to other African countries at risk of epidemics. To document the molecular characteristics of disease-causing meningococcal strains circulating in the meningitis belt of Africa before vaccine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.